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Abstract 
Compounds of pharmacological interest (alkaloids) were extracted and 
the results revealed that the extract consist of three alkaloid compounds (A, 
B & C). Compound (A) has been isolated from Anethum graveolens L. aerial 
parts by column chromatography using C6H6 : Ethanol (9:1) solvent as 
eluent.  It was found that simultaneous administration of alkaloid compound 
A (500 mg/kg/day) and cholesterol for 4 weeks, significantly (P<0.01) 
prevented the rise in serum  TC, TG, LDL-cholesterol, VLDL-cholesterol, 
atherogenic index and significantly (P<0.01) increased TAC and HDL-
cholesterol as compared to cholesterol fed control rabbits.  Thus, the results 
indicate antioxidant and hypolipidemic effect of alkaloid compound A of 
Anethum graveolens L. aerial parts. 
 
Keywords: Anethum graveolens L., Total Antioxidant Capacity, 
Antihyperlipidemic  
 
Introduction 
The alkaloids represent a group of natural products that had a major 
impact throughout history on the economic, medical, political and social 
affairs of humans. Many of these agents have potent physiological effects on 
mammalian systems as well as other organisms, and as a consequence, some 
constitute important therapeutic agents. Atropine, morphine, quinine and 
vincristine are representative of a host of agents used to treat a range of 
disease conditions that range from malaria to cancer. Therefore 
determination of total alkaloids is very important related to the quality of 
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medicinal plants (Shamsa et al., 2008). Lipids and lipoproteins abnormalities 
are preceding risk factor for cardiovascular diseases and prevalence of this in 
general population has increased considerably in last few decades. 
Hyperlipidemia contributes significantly in the prevalence and severity of 
atherosclerosis and coronary heart diseases (Gosain et al., 2010). 
Cardiovascular disease is a major cause of morbidity and mortality all over 
the world (Gupta and Jain, 2009). Increasing level of lipid leads to 
cardiovascular diseases and stroke. The underlying mechanism is increased 
LDL cholesterol, which further undergoes oxidative modification in the 
presence of free radicals (Agardh et al., 1999). The decrease LDL level with 
raised HDL cholesterol play important role against these complications. Due 
to the highly costs for synthetic drugs, probable side effects of this drugs and 
also restrictions in use of these drugs, during recent years scientists and 
researcher trying to substitute herbal plant and some natural component in 
these plants for treatment of disease (Hajizadeh et al., 2011). It is well 
established that consumption of fruit and vegetables prevents some diseases 
(Dauchet et al., 2006). 
The present work aims to isolate the alkaloid compounds from 
Anethum graveolens L. and assess their possible total antioxidant capacity 
and antihyperlipidemic activity in vivo.  
 
Materials and Methods 
Chemicals 
All chemicals were purchased from Sigma-Aldrich Co. (St. Louis, 
MO), and solvents were from E. Merck (Darmstadt, Germany). All of the 
reagents were prepared in deionized distilled water (ddH2O) to eliminate the 
contamination of metal ions.  
 
Plant material                                                                               
The aerial parts of Anethum graveolens L. plant were collected during 
the month of September 2011 from the Abu-Al-Khaseeb region (southern 
Basra), Iraq. The plant was botanically authenticated and voucher specimens 
were deposited in the Herbarium of Basra (Iraq, Basra, College of Science, 
University of Basra). The plant was air-dried under shade at room 
temperature for 3 days, after which it was grinded to a uniform powder.  
 
Preparation of extracts 
Aqueous extract of Anethum graveolens L.  
Anethum graveolens L. powder (100 g) was defatted with petroleum 
ether (40-60°C) at room temperature for 24 hours. Then, the defatted residue 
was refluxed with water for 24 hours. The residue was removed by filtration, 
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and the filtrate was concentration under vacuum, by freeze drier to afford 
8.25g. 
 
Alkaloids extract of  Anethum graveolens L.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
Fifty grams of the defatted ground of the Anethum graveolens L. 
aerial parts were extracted with methanol (100 mL) in a Soxhlet apparatus 
for 3 hours, and then evaporated to 0.5mL in vacuo. The methanolic residue 
was taken up in 10 mL of 2.5% hydrochloric acid and filtered. The aqueous 
acid solution was adjusted to pH=8 with concentrated ammonium hydroxide 
and extracted with dichloromethane (3 x 10 mL). The extracts were dried 
over magnesium sulphate and the solvent evaporated to afford 0.97g of crude 
alkaloid extract (Maiza-Benabdesselam et al., 2007).  
 
Isolation of the components of alkaloids extract 
Column chromatography was performed for separation of alkaloid 
component A (Spot with higher Rf = 0.86) from alkaloids extract. A glass 
column size (3×60 cm) was plug down to the bottom with small glass wool, 
then packed with HCl-washed silica-gel (mesh 230-400 μm). The slurry was 
prepared by dissolving 125g of silica-gel in 200ml of C6H6 : Ethanol (9:1) as 
eluent. The solid residue was then loaded to the top of the column and 
fractions of 5mL were collected and monitored by TLC. Fractions with the 
similar Rf were collected and dried at room temperature (Rispail et al., 2005).  
 
phytochemical screening of Anethum graveolens L. 
The different phytochemical tests were carried out using standard 
laboratory techniques. Alkaloids, carbohydrates, glycosides (Salkowski test) 
and saponins (Frothing test) were identified following the method of 
Sofowora, (1993). The presence terpenoids, steroids, flavonoids and tannins 
were tested using the method of Trease and Evans, (1989). Identification of 
carbohydrates and proteins was by the method of Khandelwal (2005). 
 
 Thin layer chromatography (TLC)  
The foregoing prepared alkaloid extract and the alkaloid compound A 
of Anethum graveolens L. were tested for Thin layer chromatography (TLC). 
A known volume (on drops) of this extract (1mg/1mL) were spotted on TLC 
silica gel plate (2×10 cm) using C6H6 : Ethanol (9:1) as a solvent system. 
After 15 minutes, the plates were dried using hair drier and examined under 
long wavelength 366nm ultraviolet.. The plates were also stained with 
Dragendorff’s, Mayer’s and Wagner’s reagents (Harborne, 1991). 
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Determination of toxicity (LD50) of the alkaloid compound A 
Forty mice were divided into five equal groups were used. Each 
group contains 8 mice (4male and 4 female). The first group one given 1ml 
of normal saline and was considered as a control group, while the second, 
third, fourth and fifth groups were given 2, 4, 6 and 8gm/kg body weight of 
alkaloid compound A respectively, dissolved in 1ml of normal saline. The 
last four groups were considered as treatment ones. Room temperature was 
controlled at 25±2°C with light for 12hrs, then the number of dead mice or 
any physical signs of toxicity such as writhing, gasping, palpitation, and 
decreased respiratory rate were recorded during period of 24, 48 and 72 hrs 
(Rattanakhot et al., 2007).  
 
Experimental animals and design 
Eighteen (18) adult, healthy, male albino rabbit, weighning 1.2-1.5  
kg. were used in the study. All rabbits were housed at the animal house of 
College of Veterinary Medicine, Basrah University. The animals were 
housed individually in standard metallic wire gauge cages under standard 
condition (light period 12.00a.m. to 12.00p.m., 25±2°C, relative humidity 
55% and water available ad labium. After acclimatization for 10 days they 
were divided into three groups of six animals each. Animals of Group I were 
fed on normal standard rabbit chow. Animals of Group II and III were made 
hypercholesterolemic by feeding them in addition to the normal diet, 2g/kg 
cholesterol powder mixed in 5ml soybean oil daily for 4 weeks (Gosain et 
al., 2010). Group III rabbits were also treated orally with (500 mg/kg/day) 
suspended in 1ml double distilled water simultaneously with cholesterol for 
4 weeks. 
 
Blood collection and serum biochemical analysis 
At the end of the study (4 weeks), rabbits were starved for 12 h 
before anesthetizing with diethyl ether. The blood (about 1-2 ml) was 
collected directly from the heart by syringes, centrifuged at 4000 rpm for 10 
minutes and the serum was obtained and stored at -20°C for the biochemical 
estimation. The plasma total cholesterol, triglyceride and HDL-cholesterol, 
were evaluated by enzymatic test kits (Randox Co). The LDL-cholesterol 
level was calculated by using the formula: LDLc= total cholesterol – [HDLc 
+ (triglyceride/5)], where (triglyceride/5) = VLDL-cholesterol (Fridewald et 
al., 1979). Total antioxidant capacity (TAC) was measured according to the 
method of (Koracevic et al., 2001). This method is used to measure the 
reductive power of a sample. It is based on suppression of the production of 
TBARS (Thiobarbituric acid reactive substances) in the presence of 
antioxidants. Briefly, the reactive mixture contained 0.5mL of a (10 mmol/L) 
Na-Benzoate, 0.2mL of H2O2 (10 mmol/L), 0.49 mL of phosphate buffer 
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(100 mmol/L, pH=7.4) (prepared by mixing 19.5 mL of  KH2PO4 (100 
mmol/L) with 80.5 mL of Na2HPO4 (100 mmol/L), then adjusted the pH to 
7.4) and 0.2 mL of  Fe-EDTA complex (2mmol/L) (prepared freshly by 
mixing equal volumes of EDTA (2mmol/L) and ammonium ferrous sulfate 
(2mmol/L), then left to stand at 25°C for 60 min). Ten microliters of the 
blood serum was added to the latter reactive mixture and was incubated at 
37°C for 60 min. Finally, 1 mL glacial acetic acid (20 mmol/L) and 1 mL 
thiobarbituric acid (0.8% w/v in 100 mL of 50mmole/L NaOH) was added 
and the absorbance at 532 nm was measured spectrophotometrically after 
incubation at 100°C for 10 min. Total antioxidant capacity was calculated 
according to the following formula:  
TAC (mmol/L) = (CUA) (K–A) / (K – UA) 
Where:  
 (CUA): Concentration of uric acid (mmol/L), K: Absorbance of 
control (K1 – K0),  
        A: Absorbance of sample (A1 –A0), UA: Absorbance of uric acid 
solution (UA1 - UA0). 
 
Statistical analysis 
The results are expressed as mean values ± SD and tested with 
analysis of variance followed by Student's t-test. P-values < 0.05, < 0.01 
were considered to be statistically significant. 
 
Results and Discussion 
Qualitative analysis for all extracts of Anethum graveolens L. plant 
The phytochemical screening of the aqueous extract of the earl part of 
Anethum graveolens L. showed the presence of the following: tannins, 
alkaloids, saponins, flavonoids, proteins and carbohydrates. The results 
however showed that glycosides, terpenoids and steroids were absent (Table 
1). Same table indicate that the alkaloid extract contains only alkaloid 
compounds. Alkaloids usually have marked physiological action on human 
or animals. Saponins on the other hand are of great pharmaceutical 
importance because of their relationship to compounds such as the sex 
hormones, cortisones, diuretic steroids, vitamin D and cardiac glycosides. 
Tannins like alkaloids are substances which show protein precipitation and 
are related to the physiological effects of herbal medicines. Flavonoid 
containing plants have influence on arachidonic acid metabolism, thus could 
have anti-inflammatory, antiallergic, antithrombotic or vasoprotective effects 
(Evans, 2002). The implication of all these is that this plant is of great 
medicinal importance. The presence of alkaloides in this plant has further 
confirmed its medicinal use as antihyperlipidemic agent. The results 
presented in Figure (1) and Table (2) shows that the alkaloid extract of A. 
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graveolens L. contains three components. These components are related to 
the alkaloid family because they give a positive test only with Dragendorff’s, 
Mayer’s and Wagner’s reagents (Bruno and Svoronos, 2003). The results 
revealed that the isolated alkaloid compound A by column chromatography 
technique, is one compound belong to the alkaloid family. 
 
Figure 1: Thin layer chromatography for alkaloid extract and alkaloid compound A of  
Anethum graveolens L. plant 
 
Table 1: Qualitative analysis for all extracts of Anethum graveolens L. plant 
Reagents 
Extracts 
Results Aqueous Alkaloids Compound A 
Benedect - - - No Glycosides 
Molisch + - - Carbohydrates are present 
Iodine - - - No Polysaccharides 
Dragendroff + + + 
Alkaloids are present Mayer + + + 
Wagner + + + 
Libermann-Burchard - - - No Steroids 
Frothing test + - - Saponins are present 
Salkoviski - - - No terpenoids 
1% FeCl3 + - - Tannins are present 
Biuret + - - Proteins are present 
10% lead acetate + - - Flavonoids are present Mg ribbon + - - 
 
Table 2: Thin layer chromatography for all extracts of Anethum graveolens L. plant 
Reagents UV 366 nm Dragendorff’s reagents 
Mayer’s 
reagents 
Wagner’s 
reagents 
Type of extract KE KC A KE KC A KE KC A KE KC A 
No. of spots 0.86 
0.34 
0.01 
0.86 
 
0.86 
0.34 
0.01 
0.86 
 
0.86 
0.34 
0.01 
0.86 
 
0.86 
0.34 
0.01 
0.86 
 
Results Conjugated system is 
present 
Alkaloids is present Alkaloids is 
present 
Alkaloids is 
present 
Where, KE: alkaloid Extract and KC A: alkaloid compound A 
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The toxicity and effect on general behavior of alkaloid compound A 
The mice treated with 2, 4, 6 and 8gm/kg body weight of alkaloid 
compound A did not show any drug induced physical signs of toxicity during 
the whole experimental period and no mortality was registered. Only 
behavioral changes observed included slightly weight loss and diarrhea. 
These early symptoms subsequently disappeared. 
 
Total antioxidant capacity and antihyperlipidemic effect of alkaloid 
compounds (A) of 
A. graveolens in normal and cholesterol fed rabbits 
The results of the present study demonstrated the total antioxidant 
capacity and hypolipidemic effect of alkaloid compounds (A) of Anethum 
graveolens in normal and cholesterol fed rabbits, Table (3). During the 
induction of hyperlipidemia, the increase in body weight and amount of food 
intake were not significantly different among all groups (control, cholestrol-
fed and treated group) of the study. Compared to the normal control group I, 
Serum TC, TG, LDL-cholesterol and VLDL-cholesterol levels increased 
significantly (P<0.01) in untreated control group II, whereas TAC and HDL-
cholesterol has been significantly (P<0.01) reduced in this group. 
Furthermore, the total cholesterol/HDL-cholesterol ratio and LDL-
cholesterol/HDL-cholesterol ratio were also increased significantly (P<0.01). 
Treated group III with alkaloid compound A (500 mg/kg/day) and 
cholesterol for 4 weeks, decreased TC, TG, LDL-cholesterol VLDL-
cholesterol and increased TAC and HDL-cholesterol significantly as control 
feeding group II. The ratios total cholesterol/HDL-cholesterol and LDL-
cholesterol/HDL-cholesterol were also declined significantly (P<0.01) as 
compared to cholesterol fed control rabbits.  
Table 2: Effect of alkaloid compound's (A) of Anethum graveolens on some serum 
parameters levels in normal and cholesterol fed rabbits 
 
Groups 
 
Dose 
mg/kg 
Fasting serum parameters levels Values are mean ± SEM (n=6) 
Total 
choleste
rol 
(mg/dl) 
TAC 
(mm
ol/l) 
TG 
(mg/dl
) 
HDLc 
(mg/dl) 
LDLc 
(mg/dl
) 
VLDLc 
(mg/dl) 
LDLc/ 
HDLc 
ratio 
TC/ 
HDL 
ratio 
Group 
Ⅰ 
Norma
l 
Contro
l 
122.18±
4.83 
1.58
±0.4 
96.1±2
.34 
55.09± 
2.93 
47.87± 
2.71 
19.22± 
0.85 
0.86± 
0.34 
2.21± 
0.07 
Group 
Ⅱ 
Choles
. fed 
Contro
l 
669.75±
18.7 b 
0.83
±0.3 
b 
285.4±
12.1 b 
45.27± 
7.8 b 
567.4± 
21.6 b 
57.08± 
6.4 b 
12.53± 
2.01 b 
14.79± 
2.1 b 
Group 
Ⅲ 500 
387.31±
24.7** 
1.34
±0.4
** 
155.48
±8.3** 
78.2± 
7.1** 
278.02
± 
13.7** 
31.09± 
2.7** 
3.55± 
0.45** 
4.95± 
0.96** 
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c = cholesterol, TG = triglycerides, TAC = total antioxidant capacity and Choles. fed = 
cholesterol fed control. a P<0.05, b P<0.01 when compared with normal control rabbits and 
*P<0.05, ** P<0.01 when compared with cholesterol fed control rabbits. 
Simultaneous Administration of alkaloid compound A of Anethum 
graveolens extract caused a significant decrease in serum total cholesterol, 
LDL-cholesterol, VLDL-cholesterol suggesting beneficial modulatory 
influence on cholesterol metabolism and turnover. Decline in the ratios of 
total cholesterol / HDL-cholesterol and LDL-cholesterol / HDL-cholesterol 
observed in the extract treated rabbits might be a consequence of higher 
proportion of HDL-cholesterol which reduced atherogenic risk by virtue of 
increased reverse cholesterol transport from peripheral organs to liver 
(Hermansen et al., 2003). Elevated serum triglycerides are considered as 
independent risk factor for cardiovascular disease (Dwivedi, 2004). A 
significant decline in the serum triglycerides level observed in plant extract 
treated rabbits supports the cardiovascular protective influence. Therefore, 
possible explanations for hypolipidemic effects of the alkaloid compound A 
of Anethum graveolens included that this compound could inhibit 
carbohydrate absorption and metabolism (Gosain et al., 2010). The 
cholesterol lowering effect of the plant extract is possibly associated with a 
decrease in intestinal absorption of cholesterol resulting in an increase in 
fecal excretion of neutral lipids (Purohit and Vyas, 2006). Also, it might be 
hypothesized that alkaloid compound A could inhibit lipogenesis, which in 
turn helps in treating type-IV and type-V hyperlipidemia. A large number of 
allopathic hypolipidemic drugs are currently available in the market but these 
lag behind the desired properties such as efficacy and safety on long term 
use, cost and simplicity of administration. These factors do not fulfill 
conditions for patients compliance (Davidson and Tooth, 2004). Plants and 
herbs are mines of large number of bioactive phytochemicals that might 
serve as lead for the development of effective, safe, cheap novel drugs. A 
number of medicinal plants have shown their beneficial effect on the 
cardiovascular disease (CVD) by virtue of their lipid lowering, antianginal, 
antioxidant and cardioprotective effects (Dwivedi, 2004). A significant 
elevation in the level of lipid profile in cholesterol fed rabbits might be lead 
to increased the level of lipid peroxide (TBARs) and indicates enhanced 
oxidative stress in hyperlipidemic state which implicates in development and 
progression atherosclerotic lesions in aorta (Prasad, 2005). Administrations 
of alkaloid compound A decreased lipid peroxidation in these tissues 
indicating antioxidant like activity which alleviates oxidative stress. It was 
shown that reactive oxygen species (ROS) and other oxidants could be also 
formed in the normal physiological process (Onder and Gurer, 2001).  Many 
antioxidant molecules found in blood prevent or inhibit the harmful effects 
of free radicals. Whenever there is a decrease in antioxidants and/or an 
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increase in oxidants, oxidant/antioxidant balance is impaired in favor of 
oxidants and this is known as oxidative stress (Isik and Koca, 2006). It is 
known that oxidative stress is responsible for tissue injury in many diseases 
and contributes to the development of atherosclerosis (Abuja and Albertini, 
2001). Antioxidant activity indicates the antioxidant characteristic of only 
one antioxidant, whereas total antioxidant capacity (TAC) represent the total 
antioxidant characteristic of all antioxidants found in plasma. It is 
doubtlessly more advantageous to evaluate TAC, instead of individual 
antioxidant activities. Many methods have been developed recently for this 
aim. Total radical trapping antioxidant parameter (TRAP), oxygen radical 
absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) 
are colorimetric methods previously developed to assess TAC (Erel, 2004a) 
(Erel, 2004b) (Ghiselli et al., 2000). Total antioxidant status or total 
antioxidant capacity within a matrix such as food extracxt, beverage or body 
fluid (plasma, synovial fluid etc.) should reflect contribution to reducing 
properties of the individual antioxidants or electron-donating components. 
Thus, in some instances, total antioxidant potential might indeed be more 
informative than knowledge of the levels of individual antioxidant 
constituents per second (Rahbani–Nobar et al., 1999). 
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